about
Efficiency of high-flux hemodialysis in the treatment of valproic acid intoxication.Valproate Protein Binding Is Highly Variable in ICU Patients and Not Predicted by Total Serum Concentrations: A Case Series and Literature Review.Intravenous valproate in neuropsychiatry.The effects of lithium, valproic acid, and carbamazepine during pregnancy and lactation.New perspectives of valproic acid in clinical practice.Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity.Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group reportExtracorporeal elimination in acute valproic acid poisoning.Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments.Protein binding predictions in infantsClinically relevant anti-epileptic drug interactions.Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.Hemoperfusion for the treatment of poisoning: technology, determinants of poison clearance, and application in clinical practice.Repurposing valproate, enteral clonidine, and phenobarbital for comfort in adult ICU patients: a literature review with practical considerations.Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations.Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: a retrospective study.The effect of uridine diphosphate glucuronosyltransferase (UGT)1A6 genetic polymorphism on valproic acid pharmacokinetics in Indian patients with epilepsy: a pharmacogenetic approach.No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.A model for estimating individualized valproate clearance values in children.Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients.A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.Effect of unbound clearance on binding parameters of valproic acid to serum proteins.Comparison of two binding equations for prediction of the concentration of unbound valproic acid in the serum of adult epileptic polytherapy patients.Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report.Should Pharmacies Be Included in Medication Reconciliation? A Report of Recurrent Valproic Acid Toxicity.
P2860
Q33358210-39BCD920-8B91-4631-80F1-C5A103D0C92AQ33439075-22BB937C-9C7E-47E3-B994-572041F71616Q33821319-9F509B61-016F-409E-A5CC-BC893634CE8CQ34349772-C6A25E3E-8A8F-4F29-9535-737931BD989DQ34380256-62B7C784-3108-49EF-9D97-A86E59328BB0Q34408675-0E9B32F4-48FF-4823-8B47-46A6941303B2Q34722045-B9FEABC4-1692-45EF-8952-998ED51EE85DQ34995723-F4FF13D5-D551-4BA3-81F0-D7688A16FF2EQ36662893-D1ED2EFB-89F4-42DA-9D59-5CA1F3AEBBCCQ37361786-4CD536F5-B59E-4FD4-8599-12B91C5DA0B0Q37920931-DD0BC6DE-A129-405C-B7CD-9BDF0122936AQ38181565-6D4EF098-9577-4417-B8AD-5791F97C4C50Q38211477-DC3758D0-3032-4737-871C-D5ED7755842CQ38612210-029C7ECA-03BC-4370-A5FB-3EA643653921Q42582754-4FA86695-442F-406A-8316-5C77147A4FDCQ43272818-04B3DEE1-79BE-4706-94E4-C43B5EF919F0Q44882854-E6EFF4C1-E43C-482A-8938-B34FAA2F6ED9Q45929957-0B32A95F-3C5D-4BD3-8789-5CFCCD383B2FQ46181284-340C4CB8-1003-4FF6-B69F-963C89DFAB2EQ46397769-73A26216-726E-4F33-8268-6894DFAF95EFQ51013612-C9F71130-C821-4BDB-9B08-E59AFB277D26Q51602096-D4ACE0BA-5D86-4D19-A68E-2730325969F9Q52294820-0CD761B5-CE50-46DD-B88C-44B544B7A532Q53259996-56D993B9-9A36-4BED-8684-B228E4E85C18Q55024054-94F186DE-487F-441A-83C1-22935D297194
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Clinical pharmacokinetics of valproic acid--1988.
@en
Clinical pharmacokinetics of valproic acid--1988.
@nl
type
label
Clinical pharmacokinetics of valproic acid--1988.
@en
Clinical pharmacokinetics of valproic acid--1988.
@nl
prefLabel
Clinical pharmacokinetics of valproic acid--1988.
@en
Clinical pharmacokinetics of valproic acid--1988.
@nl
P2093
P1476
Clinical pharmacokinetics of valproic acid--1988.
@en
P2093
P304
P356
10.2165/00003088-198815060-00002
P577
1988-12-01T00:00:00Z
P6179
1037779041